[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345083-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-345083-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","involvement-of-increased-arginase-1-group-2-innate-lymphoid-cells-and-myeloid-derived-suppressor-cells-in-endometrial-carcinoma-a-pilot-study","Involvement of increased arginase-1 group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma - A pilot study","","Endometrial carcinoma is a prevalent gynecologic malignancy with limited survival, and growing evidence links group 2 innate lymphoid cells (ILC2s) and myeloid-derived suppressor cells to tumor progression, yet the immunopathological basis remains incompletely defined. This pilot study evaluates immune-cell frequencies and inflammatory mediators across peripheral blood, carcinoma tissue, and para-cancerous tissue. Results show altered cytokine patterns, increased ILC2/monocytic suppressor infiltration, and associations with worse progression-free survival.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/involvement-of-increased-arginase-1-group-2-innate-lymphoid-cells-and-myeloid-derived-suppressor-cells-in-endometrial-carcinoma-a-pilot-study/345083/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/involvement-of-increased-arginase-1-group-2-innate-lymphoid-cells-and-myeloid-derived-suppressor-cells-in-endometrial-carcinoma-a-pilot-study/345083.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study conclude about immune collaboration in endometrial carcinoma?","Question",{"text":63,"@type":64},"The findings suggest a collaborative role of ILC2s and myeloid-derived suppressor cells in promoting type II immunity and contributing to endometrial carcinoma progression, with elevated marker-positive populations indicating a poor prognosis.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},345083,1790387309,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,98,103,107,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":94,"doc_module":4,"doc_module_name":25,"category_name":95,"show_sort_weight":96,"slug":97},6,"Technology",50,"technology",{"id":99,"doc_module":4,"doc_module_name":25,"category_name":100,"show_sort_weight":101,"slug":102},7,"Healthcare",40,"healthcare",{"id":104,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":105,"slug":106},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":104,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Involvement of increased arginase-11 group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma: A pilot study  \nZhangyun Gong 1, Zhimin Lu 1, Anan Pan 1,2, Hao Wang 1, Haixing Yi 1 , Peipei Guo 1, Kaihuan Bi 1, Xuqing Li 1, Ya Chen 1, Yuping Xu 1, Yunxia Cao 1, Caihua Li 1 and Huanhuan Jiang 1  \nJournal of International Medical Research 2026, Vol. 54(3) 1–11! The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605261426163](DOI: 10.1177/03000605261426163)[ ](DOI: 10.1177/03000605261426163)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nBackground: Endometrial carcinoma is a prevalent gynecologic malignancy with a relatively low survival rate. Emerging studies have demonstrated that crosstalk between group 2 innate lymphoid cells (ILC2s) and myeloid-derived suppressor cells drives tumor progression. The immunopathological mechanisms underlying endometrial carcinoma are not yet fully understood. Methods: This study assessed the frequency of innate lymphoid cells and myeloid-derived suppressor cells as well as related inflammatory mediators in peripheral blood, carcinoma tissue, and para-cancerous tissue of patients with endometrial carcinoma.  \nResults: Patients with endometrial carcinoma exhibited decreased levels of interleukin-22 and interferon-c and increased levels of interleukin-25. Infiltration of ILC2s and monocytic myeloidderived suppressor cells was elevated, while ILC3 levels were reduced. Functional analysis showed enhanced arginase-1 expression in ILC2s obtained from patients with endometrial carcinoma. Both arginase-1 þ ILC2s and monocytic myeloid-derived suppressor cells were significantly associated with poorer progression-free survival. A direct correlation between  \n1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, China 2Department of Obstetrics and Gynecology, Anqing Hospital Affiliated to Anhui Medical University (Anqing Municipal Hospital), China  \nCorresponding authors:  \nHuanhuan Jiang, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei 230022, Anhui, China.  \nEmail: [jhh198673@163.com](jhh198673@163.com)  \nCaihua Li, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, No 218 Jixi Road, Hefei 230022, Anhui, China.  \nEmail: [845313846@qq.com](845313846@qq.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \narginase-1 þ ILC2s and monocytic myeloid-derived suppressor cells suggests a synergistic role in endometrial carcinoma progression.  \nConclusion: Our study indicates that the collaborative effects of ILC2s and myeloid-derived suppressor cells promote type II immunity and may contribute to the progression of endometrial carcinoma. Elevated levels of arginase-1 þ ILC2s and monocytic myeloid-derived suppressor cells are associated with a poor prognosis in patients with endometrial carcinoma.  \nKeywords  \nArginase-1, endometrial carcinoma, innate lymphoid cells, myeloid-derived suppressor cells, poor prognosis  \nDate received: 15 September 2025; accepted: 5 February 2026  \nIntroduction  \nEndometrial carcinoma (EC) arises from the endometrial epithelium, the innermost lining of the uterus.1 Globally, approximately 42,000 women die from EC each year.2 EC represe","cbCaifif8ih2VHAP","https://ap.wps.com/l/cbCaifif8ih2VHAP","pdf",749079,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Endometrial carcinoma and immunosuppressive microenvironment\n## Innate lymphoid cell subsets and tumor microenvironment","[{\"question\":\"What does the study conclude about immune collaboration in endometrial carcinoma?\",\"answer\":\"The findings suggest a collaborative role of ILC2s and myeloid-derived suppressor cells in promoting type II immunity and contributing to endometrial carcinoma progression, with elevated marker-positive populations indicating a poor prognosis.\"}]","Involvement of increased arginase-1 group 2 innate lymphoid cells and myeloid-derived suppressor cells in endometrial carcinoma - A pilot study | PDF",1790056462,28,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8febe8a1b1859f4baabcf33e5b55bfb.webp",983,1399,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d77cfa07282b393ccc0da9082292ddcf.webp",982,1398,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09cc7a24d6b210c351a1a2506592e7e2.webp",981,1396,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41e74f70da04837baa005b12ba6d66ca.webp",980,1395]